Acoustic neuroma diagnostic study of choice

Revision as of 18:05, 26 April 2019 by Sabawoon Mirwais (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Acoustic neuroma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acoustic neuroma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography or Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acoustic neuroma diagnostic study of choice On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acoustic neuroma diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acoustic neuroma diagnostic study of choice

CDC on Acoustic neuroma diagnostic study of choice

Acoustic neuroma diagnostic study of choice in the news

Blogs on Acoustic neuroma diagnostic study of choice

Directions to Hospitals Treating Acoustic neuroma

Risk calculators and risk factors for Acoustic neuroma diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohsen Basiri M.D.

Overview

Gadolinium-enhanced MRI scan is the definitive diagnostic test for acoustic neuroma and can identify tumors as small as 1-2 millimeter in diameter. On brain MRI, acoustic neuroma characterized by hypointense mass on T1-weighted MRI, and hyperintense mass on T2-weighted MRI.

Diagnostic Study of Choice

MRI component Features
T1
  • Slightly hypointense to the adjacent brain (63%)
  • Isointense to the adjacent brain (37%)
  • May contain hypointense cystic areas
T2
T1 C+ (Gd)

Post-op MRI: Linear enhancement may not indicate tumor. But if there is nodular enhancement, suspect tumor recurrence which will necessitate follow-up MRI.[3]

MRI showing Intracanalicular acoustic neuroma[4]
MRI showing Intrameatal vestibular schwannoma[5]

References

  1. E. P. Lin & B. T. Crane (2017). "The Management and Imaging of Vestibular Schwannomas". AJNR. American journal of neuroradiology. 38 (11): 2034–2043. doi:10.3174/ajnr.A5213. PMID 28546250. Unknown parameter |month= ignored (help)
  2. D. F. Wilson, R. S. Hodgson, M. F. Gustafson, S. Hogue & L. Mills (1992). "The sensitivity of auditory brainstem response testing in small acoustic neuromas". The Laryngoscope. 102 (9): 961–964. doi:10.1288/00005537-199209000-00001. PMID 1518359. Unknown parameter |month= ignored (help)
  3. Acoustic Schwannoma. Radiopedia(2015) http://radiopaedia.org/articles/acoustic-schwannoma Accessed on October 2 2015
  4. Image courtesy of Dr Frank Gaillard. Radiopaedia (original file here).[http://radiopaedia.org/licence Creative Commons BY-SA-NC
  5. Image courtesy of Dr. Roberto Schubert Radiopaedia (original file here).[http://radiopaedia.org/licence Creative Commons BY-SA-NC

Template:WH Template:WS